Track topics on Twitter Track topics that are important to you
LONDON, September 22, 2016 /PRNewswire/ -- Report Details What can be expected from the Allergic Rhinitis Drugs Market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects. Our 240-page report provides 173 tables, charts, and graphs. Discover the most lucrative areas in...
Osaka, Japan and Ahmedabad, India, September 21, 2016 – Takeda Pharmaceutical Company Limited [TSE: 4502], (“Takeda”) and Zydus Cadila today announced a partnership to tackle chikungunya, an emerging infectious disease in Africa, Asia and the Indian subcontinent. In recent decades
BRICK, N.J., Sept. 20, 2016 /PRNewswire/ -- Sathish Reddy, President and CEO of Theranostix Inc., today announced the formation of P4 Diagnostix™, a specialized diagnostic laboratory. Theranostix Inc. acquired Platinum Pathology and Long Island Pathology earlier this year. The laboratories are now unified under the name of P4 Diagnostix™. Each laboratory will focus its se...
Hoersholm; September 20th, 2016 - Medical Prognosis Institute A/S (MPI.ST) (Denmark and Phoenix, AZ, USA) today announced that its spinout Oncology Venture Sweden AB (OV:ST) has entered a co-development agreement with Cadila Pharmaceuticals Ltd. to develop the anticancer product LiPlaCis® in combination with its Drug Response Predictor - DRP(TM). LiPlaCis® is the lead prod...
David SalazarThe drug had about $22.5 million in U.S. sales for the 12 months ended July 2016, according to IMS Health
Under a 2015 partnership, Dr. Reddy's markets and distributes a number of Amgen drugs in India. An additional three drugs will now be covered by the agreement.
Mylan and Biocon announced on 25 August 2016 that the regulatory submission for their proposed trastuzumab biosimilar (Myl-1401O) had been accepted for review by the European Medicines Agency (EMA).
A panel of Indian scientists this week said a genetically modified (GM) mustard developed by the University of Delhi poses no risk to humans, taking the mustard one step closer to being the first GM food crop in India to be approved for commercial production. According to the panel, the oilseed “does not raise any public health or safety concerns on human beings and animals with respect to overa...
David Salazar Lupin’s Avelox generic will be available in 400-mg dosage strength.
David SalazarBrand and generic sales of the drug were $109.6 million for the 12 months ended July 2016, according to IMS Health.
LONDON, September 6, 2016 /PRNewswire/ -- Revenue Forecasting of Originator, Generic and OTC Medicines and Therapy Areas Including CNS, Cardiovascular and Cancer; Exploration of Regional Differences in Healthcare; Discussion of Domestic Manufacturers Including EMS, Hypermarcas and Aché, and International Drug Companies Including Sanofi, Novartis and Roche Medicine Sales in Brazil - How to ...
LONDON, Sept. 5, 2016 /PRNewswire/ -- Report DetailsBiosimilar Drug Producers – Your 2016 Guide to Companies' Activities and ProspectsWho are the most important and promising biosimilar drug companies? And what are their sales potentials? Discover, in our updated survey, organisations' outlooks from 2016. There you see results, trends, opportunities and revenue forecasting.Visiongain's new ...
India’s third biggest drug producer Lupin Ltd (Lupin) has announced that it will purchase 21 generic medicine brands from Japanese company Shionogi & Co Ltd (Shionogi) for a total of US$150 million, bolstering its position in the large Japanese pharmaceutical market.
ONTARIO, Calif., Sept. 1, 2016 /PRNewswire/ -- Prem Reddy, MD, FACC, FCCP, Chairman, President and CEO of Prime Healthcare, has once again been named to Modern Healthcare's prestigious list of the "100 Most Influential People in Healthcare" for 2016. This is the third time that Dr. Reddy has been recognized as among the most influential healthcare leaders in the nation. "I am proud of this reco...
BENGALURU, India and HERTFORDSHIRE, England and PITTSBURGH, Aug. 25, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) announced today that the European Medicines Agency (EMA) has accepted for review Mylan's Marketing Authorization Application (MAA) for a proposed biosimilar Trastuzumab, which is used to treat certain HER2-positive breast and ...
[T]he signatory nations of the Biological Weapons Convention (BWC)
LONDON, Aug. 23, 2016 /PRNewswire/ -- Active Pharmaceutical Ingredients (APIs) are active substances in a drug intended to achieve pharmacological activity which is having direct effect on diagnosis or treatment of disease. APIs are synthesized by chemical synthesis, fermentation, biotechnological methods or enhanced from natural source. API market is mainly driven by the factors such as patent ex...
// Competitive Salary: Dr. Reddy’s: We are seeking an analytical development chemist with chromatographic development expertise, wishing to… Cambridge, UK from Job Search RSS http://ift.tt/2bn8XOt Cet article #jobs #lifescience Dr. Reddy’s: Analytical Development Chemist – Cambridge, UK est apparu en premier sur Biotech 365.
Mylan and Biocon announced on 21 July 2016 that the regulatory submission for their proposed pegfilgrastim biosimilar (LA-EP2006) had been accepted by the European Medicines Agency (EMA).
LONDON, Aug. 18, 2016 /PRNewswire/ -- About OTC DrugsOTC drugs are medicines that can be bought without a prescription from a doctor because the US FDA considers them safe for use without medical supervision. These drugs are used to treat conditions that do not necessarily require a doctor's advice, such as pain, itches, cough and cold, sleeping problems, smoking cessation, weight problems, gastro...
David SalazarLupin’s generic will be available in 600- and 800-mg dosage strengths. read more
// Competitive: Thermo Fisher Scientific: Engineer II – SystemsPosition ObjectiveWe are seeking strong candidates to support internal hardware within the Ion Torrent organization. This will i South San Francisco, California from Job Search RSS http://ift.tt/2aLLAwY Cet article #jobs #lifescience Thermo Fisher Scientific: Engineer II – Systems est apparu en premier sur Biotech 365.
The US FDA has banned products from a third Indian manufacturing plant operated by Wockhardt.
LONDON, August 8, 2016 /PRNewswire/ -- Profiles, R&D and Revenue Forecasting for Leading Syringe, Injector and Component Producers and Contract Manufacturers (CMOs); Analysis of Products Including Glass and Plastic Syringes, Cartridges, Pen Injectors, Autoinjectors, Safety Systems and Accessories; Assessment of Companies Specialising in Ready-to-Fill Drug Delivery Systems for Vaccines, Insuli...
David Salazar The products have combined U.S. sales of $3.5 billion for the 12 months ended June 2016, according to IMS Health. read more